Gloshell
成分辞典
成分一覧

成分辞典

ドデセン

DODECENE

1-dodecene is an alkene that is dodecane containing one double bond at position 1.

分子構造

定義

1-dodecene is an alkene that is dodecane containing one double bond at position 1. It is an intermediate used in the production of lubricants and surfactants. It has a role as a mammalian metabolite and a human metabolite. It is a volatile organic compound and a dodecene.

出典: PubChem

米国FDA 物質登録 · UNII WYE669F3GR · 登録名 1-Dodecene · 単一の化学物質

出典: 米国FDA 物質識別番号（UNII）

化粧品での役割

他の成分を溶かす基剤SOLVENT粘度を調整するVISCOSITY CONTROLLING香料組成に使う物質として登録（香りを出すという意味ではありません）FRAGRANCE

安全性・規制情報

韓国の有害物質GHS分類なし · 既存化学物質

出典: 韓国 有害物質GHS情報（環境公団）

詳しい資料 — 表示名・識別番号・物性・試験記録・文献

公式表示名・定義

日本化粧品工業会の表示名称 ドデセン: 本品は、次の化学式で表される不飽和炭化水素である。

出典: 日本化粧品工業会 表示名称

別名・識別情報

DODECENEINCI도데센韓国の表示名（食薬処標準名）1-Dodecene別名ドデセン日本の表示名称
CAS No.化学物質登録番号
112-41-4
EC No.EU化学物質目録番号
203-968-4
DTXSID米国EPA化学物質番号
DTXSID5026914
DTXCID米国EPA化合物番号
DTXCID306914
IUPAC
Dodec-1-ene
分子式
C12H24
分子量
168.324 g/mol

測定された物性

性状
1-dodecene appears as a clear colorless liquid with a mild, pleasnat odor. Insoluble in water and floats on water. Harmful or fatal by ingestion. Inhalation of vapors may irritate and damage lungs. High concentrations may have a narcotic effect. · Liquid, CBI
臭い
MILD, PLEASANT
沸点
415 °F at 760 mmHg (USCG, 1999) · 213.8 °C
融点
-31 °F (USCG, 1999) · -35.2 °C
溶解性
Insoluble in water, sol in ethanol, ethyl ether, and acetone · Solubility in water: none
密度
0.758 at 68 °F (USCG, 1999) - Less dense than water, will float · 0.7584 g/cu cm @ 20 °C
粘度
1.72 sq mm/s @ 20 °C · 1.72 ㎟/s
色
無色
融点・凝固点
-36~-31 ℃
初留点および沸点範囲
208~216 ℃
引火点
77 ℃((c.c.))
燃焼・爆発範囲の上限/下限
0.62 / 5.42 %
蒸気圧
0.159 ㎜Hg ( (25 ℃))
蒸気密度
5.8-5.81
比重
0.7584-0.76
n-オクタノール/水分配係数（Kow）
6.10
自然発火温度
225 ℃
分子量
168.31

物質そのものを測定した値です。安全保健公団（KOSHA）の資料はSDS作成・確認の参考用で、原料商品の規格ではありません。

出典: PubChem · 韓国安全保健公団 SDS

製品が実際に使っている用途

米国EPAにこの成分を届け出た製品23件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。

  • Lubricating agent3
  • Viscosity modifier3
  • Deodorizer2
  • Processing aids not otherwise specified2
  • Chemical reaction regulator2
  • Intermediate2
  • Monomers1
  • Diluent1
その他の用途 7件
  • Solvent1
  • Degradant/impurity (EPA)1
  • Surfactant (surface active agent)1
  • Fuel1
  • Elasticizer1
  • Defoamer1
  • Flavouring and nutrient1

出典: 米国EPA CompTox

刺激・感作試験の記録

皮膚試験18件・眼試験7件の記録があります。

刺激が強いと分類5件中程度と分類3件低いと分類30件

試験ごとに結論が分かれています（最も多い結論の割合 13%）。この成分が刺激性だとは言い切れないということです。 原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。

試験25件をすべて見る
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Category 2
    Skin Irritation · Screening
  • Classification not possible
    Skin Sensitization · Screening
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Category 6.3A (Category 2)
    Skin Irritation · Read Across
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
  • Not classified
    Eye Irritation · Screening

出典: 米国EPA CompTox

関連文献

連携データベース 20

コミュニティ

質問を投稿すると、まずGloshell AIが答え、ほかのメンバーが続きます。